InvestorsHub Logo
icon url

tradinggreen

06/13/12 8:57 PM

#25027 RE: 17yr_man #25025

Just a little bit ago you were excited about Balzer and now you think it's too late for him to establish ties to the distribution part??!

You are forgetting that market acceptance was one of the key factors in any buyout, well at least from the last conference call. I also remember the words "risk adverse". Give Balzer a chance, because at this point it may all we have?? I'm thinking he is the professional we need coming at a very key time.

icon url

held2long

06/13/12 11:18 PM

#25030 RE: 17yr_man #25025

17years - As far as funding production. I'm not sure it would be that difficult to fund. Machines are selling for $90,000, so a typical retail markup of 100% would mean $45,000 cost to produce. But this isn't typical -medication that is priced at $20/pill only costs the drug company pennies to produce - you are paying for the research - same here. Without knowing anything about Medizone's cost I would guess if these machines are priced at $90,000 it doesn't cost them more than $10,000 to produce - practically completely covered by a down payment.